Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 183
Filter
Add more filters










Publication year range
1.
Diabetes ; 50(2): 329-39, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11272144

ABSTRACT

Hyperinsulinism of infancy (HI) is a congenital defect in the regulated release of insulin from pancreatic beta-cells. Here we describe stimulus-secretion coupling mechanisms in beta-cells and intact islets of Langerhans isolated from three patients with a novel SUR1 gene defect. 2154+3 A to G SUR1 (GenBank accession number L78207) is the first report of familial HI among nonconsanguineous Caucasians identified in the U.K. Using patch-clamp methodologies, we have shown that this mutation is associated with both a decrease in the number of operational ATP-sensitive K+ channels (KATP channels) in beta-cells and impaired ADP-dependent regulation. There were no apparent defects in the regulation of Ca2+- and voltage-gated K+ channels or delayed rectifier K+ channels. Intact HI beta-cells were spontaneously electrically active and generating Ca2+ action currents that were largely insensitive to diazoxide and somatostatin. As a consequence, when intact HI islets were challenged with glucose and tolbutamide, there was no rise in intracellular free calcium ion concentration ([Ca2+]i) over basal values. Capacitance measurements used to monitor exocytosis in control and HI beta-cells revealed that there were no defects in Ca2+-dependent exocytotic events. Finally, insulin release studies documented that whereas tolbutamide failed to cause insulin secretion as a consequence of impaired [Ca2+]i signaling, glucose readily promoted insulin release. Glucose was also found to augment the actions of protein kinase C- and protein kinase A-dependent agonists in the absence of extracellular Ca2+. These findings document the relationship between SUR1 gene defects and insulin secretion in vivo and in vitro and describe for the first time KATP channel-independent pathways of regulated insulin secretion in diseased human beta-cells.


Subject(s)
ATP-Binding Cassette Transporters , Adenosine Triphosphate/physiology , Hyperinsulinism/congenital , Hyperinsulinism/metabolism , Insulin/metabolism , Islets of Langerhans/metabolism , Potassium Channels, Inwardly Rectifying , Potassium Channels/physiology , Adenosine Diphosphate/physiology , Calcium/physiology , Calcium Signaling , Cytosol/physiology , Exocytosis/physiology , Genotype , Humans , Hyperinsulinism/genetics , Hyperinsulinism/physiopathology , In Vitro Techniques , Infant, Newborn , Insulin Secretion , Islets of Langerhans/physiopathology , Molecular Sequence Data , Mutation/physiology , Patch-Clamp Techniques , Potassium Channels/genetics , Potassium Channels/metabolism , Receptors, Drug/genetics , Receptors, Drug/metabolism , Sulfonylurea Receptors
2.
J Biol Chem ; 276(5): 2979-85, 2001 Feb 02.
Article in English | MEDLINE | ID: mdl-11069902

ABSTRACT

Hexamminecobalt(III) (HAC) chloride was found to have a potent inhibitory effect on glucose-induced insulin secretion from pancreatic islets. HAC at 2 mm inhibited the secretion in response to 22.2 mm glucose by 90% in mouse islets. Perifusion experiments revealed that the first phase of insulin secretion was severely suppressed and that the second phase of secretion was completely abrogated. Removal of HAC from the perifusate immediately restored insulin secretion with a transient overshooting above the normal level. However, HAC failed to affect glucose-induced changes in d-[6-(14)C]glucose oxidation, levels of reduced forms of NAD and NADP, mitochondrial membrane potential, ATP content, cytosolic calcium concentration, or calcium influx into mitochondria. Furthermore, HAC inhibited 50 mm potassium-stimulated insulin secretion by 77% and 10 microm mastoparan-stimulated insulin secretion in the absence of extracellular Ca(2+) by 80%. The results of a co-immunoprecipitation study of lysates from insulin-secreting betaHC9 cells using anti-syntaxin and anti-vesicle-associated membrane protein antibodies for immunoprecipitation or Western blotting suggested that HAC inhibited disruption of the SNARE complex, which is normally observed upon glucose challenge. These results suggest that the inhibitory effect of HAC on glucose-induced insulin secretion is exerted at a site(s) distal to the elevation of cytosolic [Ca(2+)], possibly in the exocytotic machinery per se; and thus, HAC may serve as a useful tool for dissecting the molecular mechanism of insulin exocytotic processes.


Subject(s)
Calcium/metabolism , Chlorides/pharmacology , Cobalt/pharmacology , Exocytosis/drug effects , Glucose/pharmacology , Insulin/metabolism , Adenosine Triphosphate/metabolism , Animals , Biological Transport/drug effects , Cells, Cultured , Cyclic AMP/metabolism , Cytosol/drug effects , Cytosol/metabolism , Drug Interactions , Exocytosis/physiology , Glucose/metabolism , Insulin Secretion , Intercellular Signaling Peptides and Proteins , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Male , Mice , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/metabolism , Oxidation-Reduction/drug effects , Peptides , Potassium Chloride/pharmacology , Wasp Venoms/pharmacology
3.
Biosci Rep ; 21(5): 653-66, 2001 Oct.
Article in English | MEDLINE | ID: mdl-12168772

ABSTRACT

In rat islets, progesterone caused a prompt concentration-dependent inhibition of glucose-stimulated insulin release with an IC50 of 10 microM at 8.4mM glucose. The inhibition was specific since both testosterone and 17beta-estradiol had no such effect. The degree of inhibition was similar in islets from male and female rats. The inhibition was not blocked in PTX-treated islets thus ruling out the Gi/Go proteins as mediators of the inhibition. Progesterone inhibited both glucose- and BayK-8644-stimulated insulin secretion in HIT-T15 cells and the IC50 vs. 10 mM glucose was also 10 microM. There was no effect on intracellular cyclic AMP concentration in the presence 0.2 and 10 mM glucose. Progesterone decreased [Ca2+]i under all conditions tested. The decrease in [Ca2+]i was due to blockade of the L-type voltage-dependent Ca2+ channels. Under Ca(2+)-free conditions, progesterone did not inhibit the stimulation of insulin release due to the combination of glucose, phorbol ester and forskolin. Thus blockade of Ca2+ entry appears to be the sole mechanism by which progesterone inhibits insulin release. As progesterone covalently linked to albumin had a similar inhibitory effect as progesterone itself, it is concluded that the steroid acts at the outer surface of the beta-cell plasma membrane. These effects would be classified as either AI or AIIb in the Mannheim classification of nongenomically initiated steroid actions.


Subject(s)
Insulin/metabolism , Progesterone/pharmacology , Animals , Calcium/metabolism , Cell Line , Cells, Cultured , Cytosol/metabolism , Dose-Response Relationship, Drug , Glucose/pharmacology , Insulin Secretion , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Male , Progesterone/administration & dosage , Rats , Rats, Wistar
4.
Endocr J ; 48(6): 647-54, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11873862

ABSTRACT

Inhibition of insulin release by norepinephrine has been attributed to activation of ATP-sensitive K+ channels, inactivation of voltage-dependent Ca2+ channels, and inhibition of adenylyl cyclase. However, direct inhibitory action of norepinephrine at a distal site of stimulus-secretion coupling has also been suggested. To obtain more direct evidence for norepinephrine inhibition of insulin release at a distal site, we performed experiments in intact, non-permeabilized beta cells. In rat pancreatic islets, a combination of glucose, phorbol ester and forskolin under stringent Ca2+-free conditions was used as a trigger of insulin exocytosis at a distal site. Norepinephrine inhibited this Ca2+-independent insulin release in a concentration-dependent manner, with an IC50 of 50 nM. The inhibition was complete, reversible, and pertussis toxin-sensitive, and not associated with any reduction of cAMP content in the islet cells. In conclusion, norepinephrine strongly, yet reversibly, inhibits insulin release in intact beta cells at a late step of exocytosis, through pertussis toxin-sensitive, G protein-mediated mechanism(s).


Subject(s)
Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Norepinephrine/pharmacology , Adenylate Cyclase Toxin , Adenylyl Cyclases/metabolism , Animals , Calcium/physiology , Colforsin/metabolism , Cyclic AMP/biosynthesis , Glucose/metabolism , Insulin Secretion , Islets of Langerhans/metabolism , Male , Pertussis Toxin , Rats , Tetradecanoylphorbol Acetate/metabolism , Virulence Factors, Bordetella/pharmacology
5.
Cell Calcium ; 27(3): 163-73, 2000 Mar.
Article in English | MEDLINE | ID: mdl-11007129

ABSTRACT

Norepinephrine (NE) is an inhibitor of insulin secretion that acts, in part, by decreasing intracellular free calcium ([Ca2+]i). We examined the effects of NE on [Ca2+]i in individual HIT-T15 cells loaded with indo 1. Cells were categorized as oscillators or non-oscillators on the basis of the pattern of the calcium response to glucose and the effect of NE on [Ca2+]i was subsequently measured in each cell. NE caused a simple decrease in [Ca2+]i in nonoscillators. In oscillators, NE decreased the amplitude and frequency of the oscillations. Furthermore, the duration of the NE effect in oscillators was longer than in non-oscillators. NE did not affect the rise in [Ca2+]i elicited by depolarizing concentrations of 20 mM or 35 mM KCl alone, or in the presence of 20 mM KCl, 100 microM diazoxide, and 10 mM glucose. In other experiments, NE had no effect on [Ca2+]i when the KATP channels were fully clamped with diazoxide or tolbutamide. We conclude that the action of NE to decrease [Ca2+]i in both oscillators and non-oscillators is mediated via activation of the KATP channel. Despite this common mechanism, NE exerts different effects on oscillating and non-oscillating cells.


Subject(s)
Calcium Signaling , Calcium/metabolism , Glucose/pharmacology , Islets of Langerhans/drug effects , Norepinephrine/pharmacology , Potassium Channels/metabolism , Adenosine Triphosphate/metabolism , Animals , Cricetinae , Cytophotometry , Diazoxide/pharmacology , Hypoglycemic Agents/pharmacology , Islets of Langerhans/metabolism , Potassium Chloride/pharmacology , Tolbutamide/pharmacology , Tumor Cells, Cultured , Vasodilator Agents/pharmacology
6.
Diabetes ; 49(5): 712-7, 2000 May.
Article in English | MEDLINE | ID: mdl-10905478

ABSTRACT

Nutrients such as glucose stimulate insulin release from pancreatic beta-cells through both ATP-sensitive K+ channel-independent and -dependent mechanisms, which are most likely interrelated. Although little is known of the molecular basis of ATP-sensitive K+ channel-independent insulinotropic nutrient actions, mediation by cytosolic long-chain acyl-CoA has been implicated. Because protein acylation might be a sequel of cytosolic long-chain acyl-CoA accumulation, we examined if this reaction is engaged in nutrient stimulation of insulin release, using cerulenin, an inhibitor of protein acylation. In isolated rat pancreatic islets, cerulenin inhibited the glucose augmentation of Ca2+-stimulated insulin release evoked by a depolarizing concentration of K+ in the presence of diazoxide and Ca2+-independent insulin release triggered by a combination of forskolin and phorbol ester under stringent Ca2+-free conditions. Cerulenin inhibition of glucose effects was concentration dependent, with a 50% inhibitory concentration (IC50) of 5 microg/ml and complete inhibition at 100 microg/ml. Cerulenin also inhibited augmentation of insulin release by alpha-ketoisocaproate, a mitochondrial fuel. Furthermore, cerulenin abolished augmentation of both Ca2+-stimulated and Ca2+-independent insulin release by 10 micromol/l palmitate, which causes palmitoylation of cellular proteins. In contrast, cerulenin did not attenuate insulin release elicited by nonnutrient secretagogues, such as a depolarizing concentration of K+, activators of protein kinases A and C, and mastoparan. Glucose oxidation, ATP content in islets, and palmitate oxidation were not affected by cerulenin. In conclusion, cerulenin inhibits nutrient augmentation of insulin release with a high selectivity. The finding is consistent with a prominent role of protein acylation in the process of beta-cell nutrient sensing.


Subject(s)
Animal Nutritional Physiological Phenomena , Cerulenin/pharmacology , Insulin Antagonists/pharmacology , Islets of Langerhans/metabolism , Acylation/drug effects , Adenosine Triphosphate/metabolism , Animals , Calcium/physiology , Drug Synergism , Glucose/metabolism , Glucose/pharmacology , Male , Osmolar Concentration , Oxidation-Reduction/drug effects , Palmitic Acid/metabolism , Palmitic Acid/pharmacology , Potassium Chloride/pharmacology , Proteins/metabolism , Rats , Rats, Wistar
7.
J Biol Chem ; 275(25): 18777-84, 2000 Jun 23.
Article in English | MEDLINE | ID: mdl-10751384

ABSTRACT

The extracellular, G protein-linked Ca(2+)-sensing receptor (CaSR), first identified in the parathyroid gland, is expressed in several tissues and cells and can be activated by Ca(2+) and some other inorganic cations and organic polycations. Calcimimetics such as NPS (R)-N-(3-phenylpropyl)-alpha-methyl-3-methoxybenzylamine hydrochloride (R-467), a phenylalkylamine, are thought to activate CaSR by allosterically increasing the affinity of the receptor for Ca(2+). When tested for its effect on insulin release in C57BL/6 mice, R-467 had no effect under basal conditions but enhanced both phases of glucose-stimulated release. The betaHC9 cell also responded to R-467 and to the enantiomer S-467 with a stimulation of insulin release. In subsequent studies with the betaHC9 cell, it was found that the stimulatory effect was due to activation of a nonspecific cation channel, depolarization of the beta-cell, and increased Ca(2+) entry. No other stimulatory mechanism was uncovered. The depolarization of the cell induced by the calcimimetic could be due to a direct action on the channel or via the CaSR. However, it appeared not to be mediated by G(i), G(o), G(q/11), or G(s). The novel mode of action of the calcimimetic, combined with the glucose-dependence of the stimulation on islets, raises the possibility of a totally new class of drugs that will stimulate insulin secretion during hyperglycemia but which will not cause hypoglycemia.


Subject(s)
Aniline Compounds/pharmacology , Calcium/agonists , Insulin/metabolism , Islets of Langerhans/drug effects , Animals , Cell Line , Insulin Secretion , Ion Channels/agonists , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Membrane Potentials/drug effects , Mice , Mice, Inbred C57BL , Molecular Mimicry , Rats , Rats, Sprague-Dawley
8.
J Biol Chem ; 274(48): 34343-9, 1999 Nov 26.
Article in English | MEDLINE | ID: mdl-10567411

ABSTRACT

The role of the calcium-binding protein, calbindin-D(28k) in potassium/depolarization-stimulated increases in the cytosolic free Ca(2+) concentration ([Ca(2+)](i)) and insulin release was investigated in pancreatic islets from calbindin-D(28k) nullmutant mice (knockouts; KO) or wild type mice and beta cell lines stably transfected and overexpressing calbindin. Using single islets from KO mice and stimulation with 45 mM KCl, the peak of [Ca(2+)](i) was 3.5-fold greater in islets from KO mice compared with wild type islets (p < 0.01) and [Ca(2+)](i) remained higher during the plateau phase. In addition to the increase in [Ca(2+)](i) in response to KCl there was also a significant increase in insulin release in islets isolated from KO mice. Evidence for modulation by calbindin of [Ca(2+)](i) and insulin release was also noted using beta cell lines. Rat calbindin was stably expressed in betaTC-3 and betaHC-13 cells. In response to depolarizing concentrations of K(+), insulin release was decreased by 45-47% in calbindin expressing betaTC cells and was decreased by 70-80% in calbindin expressing betaHC cells compared with insulin release from vector transfected betaTC or betaHC cells (p < 0.01). In addition, the K(+)-stimulated intracellular calcium peak was markedly inhibited in calbindin expressing betaHC cells compared with vector transfected cells (225 nM versus 1,100 nM, respectively). Buffering of the depolarization-induced rise in [Ca(2+)](i) was also observed in calbindin expressing betaTC cells. In summary, our findings, using both isolated islets from calbindin-D(28k) KO mice and beta cell lines, establish a role for calbindin in the modulation of depolarization-stimulated insulin release and suggest that calbindin can control the rate of insulin release via regulation of [Ca(2+)](i).


Subject(s)
Calcium/metabolism , Insulin/metabolism , S100 Calcium Binding Protein G/physiology , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , Calbindins , Immunohistochemistry , Insulin Secretion , Islets of Langerhans/cytology , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Mice , Mice, Knockout , Mutation , Potassium Chloride/pharmacology , Rats , Recombinant Fusion Proteins/drug effects , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , S100 Calcium Binding Protein G/genetics , S100 Calcium Binding Protein G/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Tissue Distribution , Tumor Cells, Cultured
9.
Diabetes ; 48(9): 1686-90, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10480595

ABSTRACT

The mechanisms underlying the first phase of glucose-stimulated insulin release, the deterioration of which marks the early stages of both type 1 and type 2 diabetes, are essentially unknown. Among many hypotheses, one holds that the first phase is due to a readily releasable pool of insulin-containing granules. We used current knowledge of the mechanisms of exocytosis and the proteins involved in docking granules at the plasma membrane to test this hypothesis. A docked pool of readily releasable granules was identified by immunoprecipitation of the plasma membrane protein syntaxin with a specific antibody and by co-immunoprecipitation of soluble N-ethylmaleimide-sensitive factor attachment protein-25 (SNAP-25) and the granule proteins synaptobrevin and synaptotagmin. The four SNARE proteins co-immunoprecipitated each other, thus identifying the core complex associated with docked granules. Using co-immunoprecipitation as a marker for docked granules, we found that the docked pool was rapidly discharged during the first phase of glucose-stimulated insulin release and refilled during the second phase. Other secretagogues also released the pool, whereas the physiological inhibitor norepinephrine blocked its release. Further studies on the nature of this pool of granules should shed light on the causes of its deterioration in the early stages of diabetes and the reasons for deficient insulin release.


Subject(s)
Cytoplasmic Granules/physiology , Glucose , Insulin/metabolism , Animals , Cell Line , Exocytosis/physiology , Insulin Secretion , Intercellular Signaling Peptides and Proteins , Islets of Langerhans/cytology , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Membrane Proteins/physiology , Norepinephrine/physiology , Peptides , Potassium Chloride/pharmacology , Stimulation, Chemical , Wasp Venoms/pharmacology
10.
Diabetes ; 48(5): 1006-12, 1999 May.
Article in English | MEDLINE | ID: mdl-10331404

ABSTRACT

Cyclic AMP potentiates glucose-stimulated insulin release by actions predominantly at a site, or sites, distal to the elevation of the cytosolic free Ca2+ concentration ([Ca2+]i). Glucose also acts at a site, or sites, distal to the elevation of [Ca2+]i via the ATP-sensitive K+ channel (K+ATP channel)-independent signaling pathway. Accordingly, using rat pancreatic islets, we studied the location of the action of cAMP and its interaction with the glucose pathway. Forskolin, an activator of adenylyl cyclase, raised intracellular cAMP levels and enhanced KCl-induced (Ca2+ -stimulated) insulin release in the presence, but not in the absence, of glucose. Thus, cAMP has no direct effect on Ca2+ -stimulated insulin release. The interaction between cAMP and glucose occurs at a step distal to the elevation of [Ca2+]i because forskolin enhancement of KCl-induced insulin release, in the presence of glucose, was demonstrated in the islets treated with diazoxide, a K+ATP channel opener. The enhancement of insulin release was not associated with any increase in [Ca2+]i. Furthermore, the interaction between cAMP and glucose was unequivocally observed even under stringent Ca2+ -free conditions, indicating the Ca2+ -independent action of cAMP. This action of cAMP is physiologically relevant, because not only forskolin but also glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide, and pituitary adenylyl cyclase activating polypeptide exerted similar actions. In conclusion, the cAMP/protein kinase A pathway has no direct effect on Ca2+ -stimulated insulin exocytosis. Rather, it strongly potentiates insulin release by increasing the effectiveness of the K+ATP channel-independent action of glucose.


Subject(s)
Cyclic AMP/pharmacology , Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/metabolism , Potassium Channels/physiology , Signal Transduction , Adenosine Triphosphate/pharmacology , Animals , Calcium/pharmacology , Colforsin/pharmacology , Cyclic AMP/metabolism , Diazoxide/pharmacology , Enzyme Activation/drug effects , Insulin Secretion , Islets of Langerhans/drug effects , Male , Potassium Chloride/pharmacology , Protein Kinase C/metabolism , Rats , Rats, Wistar , Tetradecanoylphorbol Acetate/pharmacology
11.
J Biol Chem ; 273(32): 20300-7, 1998 Aug 07.
Article in English | MEDLINE | ID: mdl-9685380

ABSTRACT

Recently, a mitochondrial mutation was found to be associated with maternally inherited diabetes mellitus (Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y, Sakura, H., Awata, T., Goto, Y., Hayakawa, T., Matsuoka, K., Kawamori, R., Kamada, T., Horai, S., Nonaka, I., Hagura, R., Akanuma, Y., and Yazaki, Y. (1994) N. Engl. J. Med. 330, 962-968). In order to elucidate its etiology, we have investigated the involvement of mitochondrial function in insulin secretion. Culture of the pancreatic beta-cell line, betaHC9, with low dose ethidium bromide (EB) (0.4 microg/ml) for 2-6 days resulted in a substantial decrease in the transcription level of mitochondrial DNA (to 10-20% of the control cells) without changing its copy number, whereas the transcription of nuclear genes was grossly unaffected. Electron microscopic analysis revealed that treatment by EB caused morphological changes only in mitochondria and not in other organelles such as nuclei, endoplasmic reticula, Golgi bodies, or secretory granules. When the cells were treated with EB for 6 days, glucose (20 mM) could no longer stimulate insulin secretion, while glibenclamide (1 microM) still did. When EB was removed after 3- or 6-day treatment, mitochondrial gene transcription recovered within 2 days, and the profiles of insulin secretion returned to normal within 7 days. Studies with fura-2 indicated that in EB-treated cells, glucose (20 mM) failed to increase intracellular Ca2+, while the effect of glibenclamide (1 microM) was maintained. Our system provides a unique way to investigate the relationship between mitochondrial function and insulin secretion.


Subject(s)
DNA, Mitochondrial/genetics , Ethidium/pharmacology , Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Transcription, Genetic/drug effects , Animals , Calcium/metabolism , Cell Line , Fura-2/metabolism , Glucokinase/metabolism , Glyburide/pharmacology , Hexokinase/metabolism , Hypoglycemic Agents/pharmacology , Insulin Secretion , Mice , Microscopy, Electron , Mitochondria/drug effects , Mitochondria/ultrastructure , Phosphorylation , RNA, Messenger/drug effects
12.
Diabetes ; 47(7): 1053-7, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9648828

ABSTRACT

Mastoparan, a tetradecapeptide component of wasp venom, activates heterotrimeric G-proteins and stimulates exocytosis in several cell types, including the pancreatic beta-cell. In this study, its effects on insulin secretion were assessed in both rat and human pancreatic islets, along with the ability of glucose and alpha-ketoisocaproate (alpha-KIC) to augment mastoparan-stimulated release. In Ca2+-free Krebs-Ringer bicarbonate buffer containing 2.8 mmol/l glucose, 20 micromol/l mastoparan stimulated insulin secretion 12- and 14-fold in rat and human islets, respectively. The inactive analog mastoparan-17 had no effect on release. Under the same Ca2+-free conditions, 11.1 mmol/l glucose had no effect on insulin release alone, but augmented mastoparan-stimulated release by 74% in both rat and human islets. Stimulation of release by mastoparan and augmentation of release by glucose were unaffected by treatment with pertussis toxin. The effect of cellular GTP depletion on the mastoparan stimulation of release and augmentation by alpha-KIC was studied by culturing rat islets in the presence of 25 microg/ml mycophenolic acid for 20 h. In the control islets, alpha-KIC augmented mastoparan-stimulated insulin release by 80%. In the GTP-depleted rat islets, mastoparan-stimulated insulin release was not changed, while the augmentation by alpha-KIC was eliminated. Mannoheptulose completely blocked the augmentation by glucose. In conclusion, mastoparan stimulates insulin release by activation of a signal transduction pathway that can be augmented by nutrients such as glucose and alpha-KIC. Nutrient augmentation of this pathway is heavily dependent on GTP.


Subject(s)
Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Wasp Venoms/pharmacology , Adenosine Triphosphate/metabolism , Animals , Calcium/administration & dosage , Colforsin/pharmacology , Guanosine Triphosphate/metabolism , Guanosine Triphosphate/pharmacology , Humans , Insulin Secretion , Intercellular Signaling Peptides and Proteins , Keto Acids/pharmacology , Male , Mannoheptulose/pharmacology , Organ Culture Techniques , Peptides , Pertussis Toxin , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Virulence Factors, Bordetella/pharmacology
13.
Diabetes ; 47(5): 758-63, 1998 May.
Article in English | MEDLINE | ID: mdl-9588447

ABSTRACT

Insulin secretion by isolated islets of Langerhans from 19 human donors (9 women and 10 men) was studied in vitro to test the hypothesis that human islets contain both the K(ATP) channel-dependent and the K(ATP) channel-independent signaling pathways. The results demonstrated the presence of both of these major pathways of glucose signaling. Thus, insulin secretion was stimulated by high glucose concentrations, by the sulfonylurea tolbutamide, and by a depolarizing concentration of potassium chloride. Diazoxide, which activates the K(ATP) channel, completely blocked the stimulation of release by glucose. Stimulation of insulin release by tolbutamide, which inhibits the K(ATP) channel and depolarizes the beta-cell, and inhibition of glucose-stimulated release by diazoxide, which activates the channel and repolarizes the beta-cell, confirm the involvement of the K(ATP) channel-dependent pathway in glucose signaling. The participation of the K(ATP) channel-independent pathway in the stimulation of insulin release by glucose was demonstrated for the first time in human islets. This was done in two ways. The first method, in the presence of diazoxide, blocked the action of glucose on the K(ATP) channel in combination with a depolarizing concentration of KCl to raise [Ca2+]i. Under these conditions, glucose stimulated insulin release. A second method to demonstrate the involvement of the K(ATP) channel-independent pathway was to close the K(ATP) channels with tolbutamide. Again, with no possibility of further action on the K(ATP) channel, glucose stimulated insulin release. In a final series of experiments, glucose-stimulated insulin release was profoundly inhibited by somatostatin, clonidine, and prostaglandin E2, but not by galanin.


Subject(s)
Adenosine Triphosphate/physiology , Insulin/metabolism , Islets of Langerhans/physiology , Potassium Channels/physiology , Signal Transduction/physiology , Adrenergic alpha-Agonists/pharmacology , Adult , Clonidine/pharmacology , Dinoprostone/pharmacology , Female , Galanin/pharmacology , Glucose/pharmacology , Humans , Hypoglycemic Agents/pharmacology , In Vitro Techniques , Insulin Secretion , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Male , Middle Aged , Potassium Channels/drug effects , Secretory Rate/drug effects , Signal Transduction/drug effects , Somatostatin/pharmacology , Tolbutamide/pharmacology
14.
Diabetes ; 47(6): 905-12, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9604867

ABSTRACT

Carbachol-stimulated insulin release in the RINm5F cell is associated with elevation of the cytosolic Ca2+ concentration ([Ca2+]i) through mobilization of Ca2+ from thapsigargin-sensitive intracellular stores and with the generation of diacylglycerol (DAG). Thus carbachol activates phospholipase C, and this was thought to be the means by which it stimulates insulin secretion. However, when the elevation of [Ca2+]i was blocked by thapsigargin, the effect of carbachol to stimulate insulin release was unchanged. Thus the effect of carbachol to increase [Ca2+]i was dissociated from the stimulation of release. When the role of protein kinase C (PKC) was examined, carbachol-stimulated insulin release was found to be unaffected by phorbol ester-induced downregulation of PKC, using 12-O-tetradecanoylphorbol-13-acetate (TPA), and by the PKC inhibitors staurosporine, bisindolylmaleimide, and 1-O-hexadecyl-2-O-methylglycerol (AMG-C16). These treatments abolished the stimulation of release by TPA. Thus the carbachol activation of PKC appeared also to be dissociated from the stimulation of insulin release. However, when the activation of several different PKC isozymes was studied, an atypical PKC isozyme, zeta, was found to be translocated by carbachol. By Western blotting analysis, carbachol selectively translocated the conventional PKC isozymes alpha and beta (the activation of which is dependent on Ca2+ and DAG) from the cytosol to the membrane. Carbachol also translocated the atypical PKC isozyme zeta, which is insensitive to Ca2+, DAG, and phorbol esters. The PKC inhibitors staurosporine, bisindolylmaleimide, and AMG-C16 blocked the stimulated translocation of PKC-alpha and -beta, but not that of PKC-zeta. Prolonged treatment of the cells with TPA downregulated PKC-alpha and -beta, but not PKC-zeta. Under all these conditions, carbachol-stimulated insulin release was unaffected. However, a pseudosubstrate peptide inhibitor specific for PKC-zeta inhibited the translocation of PKC-zeta and 70% of the carbachol-stimulated insulin secretion. The data indicate that carbachol-stimulated insulin release in RINm5F cells is mediated to a large degree by the activation of the atypical PKC isozyme zeta.


Subject(s)
Carbachol/pharmacology , Insulin/metabolism , Isoenzymes/metabolism , Protein Kinase C/metabolism , Animals , Cell Membrane/enzymology , Cytosol/enzymology , Enzyme Activation , Enzyme Inhibitors/pharmacology , Insulin Secretion , Insulinoma , Isoenzymes/biosynthesis , Pancreatic Neoplasms , Protein Kinase C/biosynthesis , Staurosporine/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
15.
Endocrinology ; 139(3): 1172-83, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9492052

ABSTRACT

To delineate the underlying mechanisms by which glucose augments both Ca2+-dependent and Ca2+-independent insulin release, the latter induced by the simultaneous activation of protein kinases A and C, we examined the effects of GTP depletion by mycophenolic acid (MPA), an inhibitor of GTP synthesis, on the augmentation of insulin release from rat pancreatic islets. MPA treatment reduced GTP content by 30-40% and completely abolished glucose-induced augmentation of Ca2+-independent insulin release. Thus, this pathway is extremely sensitive to a decrease in cellular GTP content. Complete inhibition was also observed in islets treated with MPA plus adenine, to maintain ATP levels, under which conditions GTP is selectively depleted. Provision of guanine, which increases the activity of a salvage pathway for GTP synthesis and normalizes GTP content, completely reversed the inhibitory effect of MPA. Neither glucose utilization nor glucose oxidation was affected by MPA. The augmentation of Ca2+-independent insulin release by several other metabolizable nutrients including alpha-ketoisocaproic acid (KIC) was also inhibited by MPA. In sharp contrast, augmentation of Ca2+-dependent insulin release by KIC was resistant to GTP depletion, indicating that nutrient-induced augmentation of the Ca2+-dependent- and Ca2+-independent secretory pathways can be differentiated by GTP dependency. We interpret these data in accord with current knowledge concerning the two known stimuli for exocytosis, Ca2+ and GTP (independently of Ca2+). We propose that both Ca2+-dependent and Ca2+-independent augmentation occurs via one metabolic pathway acting upon Ca2+- and upon GTP-stimulated exocytosis. Activation of PKA and PKC stimulates the GTP-sensitive exocytosis.


Subject(s)
Calcium/physiology , Guanosine Triphosphate/physiology , Insulin/metabolism , Islets of Langerhans/metabolism , Adenosine Triphosphate/analysis , Animals , Colforsin/pharmacology , Glucose/metabolism , Glucose/pharmacology , Guanosine Triphosphate/analysis , Insulin Secretion , Male , Mycophenolic Acid/pharmacology , Rats , Rats, Sprague-Dawley , Tetradecanoylphorbol Acetate/pharmacology
16.
Diabetes ; 47(3): 352-7, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9519739

ABSTRACT

Under Ca2+-free conditions, activation of the pancreatic beta-cell with forskolin and 12-O-tetradecanoylphorbol 13-acetate (TPA) is permissive for the augmentation of insulin release by glucose and other nutrients. The ability of fatty acids to mimic the effect of glucose and thereby augment insulin secretion in the absence of extracellular Ca2+ is the focus of the present study. In the absence of extracellular Ca2+, glucose, palmitate, and myristate had no effect on insulin release. When, under Ca2+-free conditions, the islets were treated with forskolin to raise cyclic AMP levels and activate protein kinase A and with TPA to activate protein kinase C, glucose, palmitate, and myristate all augmented release to approximately the same extent. No other saturated fatty acid with chain lengths in the C = 6-22 range augmented the release of insulin. This selective augmentation by palmitate or myristate was not seen with forskolin alone, and was seen slightly with TPA and strongly with the combination of forskolin and TPA. The response, which developed slowly and had a time course similar to that of second-phase insulin release, was abolished by the physiological inhibitor norepinephrine. The results suggest that the mechanism underlying the Ca2+-independent augmentation of insulin release by glucose and other nutrients involves the proposed malonyl-CoA/long-chain acyl-CoA pathway with specificity for myristoyl- and palmitoyl-CoA esters and/or their derivatives.


Subject(s)
Calcium/deficiency , Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/metabolism , Myristic Acid/pharmacology , Palmitates/pharmacology , Animals , Colforsin/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , In Vitro Techniques , Insulin Secretion , Islets of Langerhans/cytology , Islets of Langerhans/drug effects , Male , Malonyl Coenzyme A/drug effects , Malonyl Coenzyme A/metabolism , Osmolar Concentration , Perfusion , Rats , Rats, Sprague-Dawley , Tetradecanoylphorbol Acetate/pharmacology , Time Factors
17.
Trends Pharmacol Sci ; 19(12): 496-9, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9871411

ABSTRACT

For normal glucose homeostasis, insulin release by the pancreatic beta cell is vital. Until recently, it was thought that glucose-induced ionic events, such as closure of the ATP-sensitive K+ (KATP) channels, membrane depolarization, activation of the L-type voltage-dependent Ca2+ channels, Ca2+ influx and elevation of cytosolic free Ca2+, constitute the main signalling pathway in beta-cell stimulus-secretion coupling. However, since the discovery of 'non-ionic' glucose actions in the beta cell by the Aizawa and Henquin laboratories in 1991, data have accumulated that strongly indicate the physiological relevance of this signalling pathway. In this review, Toru Aizawa and colleagues discuss how the KATP channel-Ca2+ hypothesis was formulated, what was overlooked in the hypothesis, and then provide a comprehensive view of stimulus-secretion coupling in the beta cell, with an emphasis on non-ionic glucose actions.


Subject(s)
Glucose/physiology , Insulin/metabolism , Islets of Langerhans/physiology , Adenosine Triphosphate/metabolism , Animals , Calcium/metabolism , Glucagon/pharmacology , Glucagon-Like Peptide 1 , Insulin Secretion , Peptide Fragments/pharmacology , Potassium Channels/physiology , Protein Precursors/pharmacology , Rats
18.
Diabetes ; 46(12): 1928-38, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9392476

ABSTRACT

Glucose stimulates insulin secretion in the pancreatic beta-cell by means of a synergistic interaction between at least two signaling pathways. One, the K(ATP) channel-dependent pathway, increases the entry of Ca2+ through voltage-gated channels by closure of the K(ATP) channels and depolarization of the beta-cell membrane. The resulting increase in [Ca2+]i stimulates insulin exocytosis. The other, a K(ATP) channel-independent pathway, requires that [Ca2+]i be elevated and augments the Ca2+-stimulated release. These mechanisms are in accord with the belief that glucose-stimulated insulin secretion has an essential requirement for extracellular Ca2+ and increased [Ca2+]i. However, when protein kinases A and C are activated simultaneously, a large effect of glucose to augment insulin release can be seen in the absence of extracellular Ca2+, under conditions in which [Ca2+]i is not increased, and even when [Ca2+]i is decreased to low levels by intracellular chelation with BAPTA. In the presence or absence of Ca2+, there are similarities in the characteristics of augmentation of insulin release that suggest that only one augmentation mechanism may be involved. These similarities include time course, glucose dose-responses, augmentation by nutrients other than glucose such as alpha-ketoisocaproate (alpha-KIC), and augmentation by the fatty acids palmitate and myristate. However, augmentation in the presence and absence of Ca2+ is distinctly different in GTP dependency. Therefore, exocytosis under these two conditions appears to be triggered differently-one by Ca2+ and the other by GTP or a GTP-dependent mechanism. The augmentation pathways are likely responsible for time-dependent potentiation of secretion and for the second phase of glucose-stimulated insulin release.


Subject(s)
Calcium/pharmacology , Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Animals , Guanosine Triphosphate/pharmacology , Humans , Insulin Secretion , Potassium Channels/physiology , Signal Transduction
19.
Diabetes ; 46(9): 1419-23, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9287041

ABSTRACT

Carbachol can stimulate insulin release in RINm5F cells by a mechanism that does not involve the elevation of cytosolic free Ca2+ concentrations or the activation of conventional protein kinase Cs (Mol Pharmacol 47:863-870, 1995). Thus, a novel signal transduction pathway links the muscarinic activation of the cells to increased insulin secretion. The question arises as to whether the pathway results from a novel receptor, different from the five established muscarinic receptors, or whether a "normal" receptor in the RINm5F cell activates a novel pathway. To distinguish between these two possibilities, the muscarinic receptors in the RINm5F cell were identified. Using polymerase chain reaction, combined with subcloning and DNA sequencing techniques, the cDNAs that encode the established M3 and M4 receptors were identified. The cDNAs for the Ml, M2, and M5 receptors were not found. Pharmacological studies showed a rank order of potency for muscarinic receptor subtype antagonists to inhibit carbachol-induced insulin release (half-maximal inhibitory concentration [pIC50] values given in parentheses): atropine (nonselective, 9.0) > 4-diphenyl-acetoxy-N-methyl piperidine methiodide (M3/M1, 8.6) > para-fluoro-hexahydrosiladiphenidol (M3, 8.1) > hexahydrosiladiphenidol (M3, 8.0) > tropicamide (M4, 6.4) > pirenzepine (M1, 6.1) > methoctramine (M2, 5.9). This antagonist profile suggests that it is the M3 receptor that mediates carbachol-induced insulin release. In this case, the novel signaling involved in the unusual carbachol response would not be due to a novel receptor but to the well-characterized M3 receptor. It appears, therefore, that the novel portion of the signaling pathway lies downstream of the M3 receptor and may consist of products of phosphatidylinositol hydrolysis, other than inositol triphosphate and diacylglycerol, resulting from the activation of phospholipase C. While a contributory role of the M4 receptor cannot be ruled out, there is no evidence in its favor other than its presence in the cell.


Subject(s)
Receptors, Muscarinic/classification , Animals , Base Sequence , Brain Chemistry , Carbachol/pharmacology , Cloning, Molecular , Insulin/metabolism , Insulin Secretion , Myocardium/chemistry , Polymerase Chain Reaction/methods , RNA, Messenger/genetics , Rats
20.
Diabetes ; 46(3): 401-7, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9032095

ABSTRACT

Activated receptors for galanin and norepinephrine, and for several other agonists, inhibit insulin release from pancreatic beta-cells via pertussis toxin-sensitive Gi- and Go-proteins and by acting on at least four cellular mechanisms. These mechanisms include repolarization via activation of the ATP-sensitive potassium (K ATP) channel, inhibition of adenylyl cyclase, and inhibition by unknown mechanism at a "distal" site. For norepinephrine and galanin there is also inhibition of the L-type Ca2+ channel. Consequently, during simultaneous activation by multiple agonists, the effectiveness with which a receptor interacts with the G-proteins will, to some extent, determine the responses. This could have important consequences for the beta-cell. Therefore, the G-protein interactions of two activated receptors, those for norepinephrine and galanin, were compared in the same beta-cell membranes. Measurements were made of the rates of receptor-G-protein interaction (by GTPgammaS binding) and of the rates of turnover of G-proteins (by GTPase activity). A comparison was also made of the ability of norepinephrine and galanin to facilitate ADP ribosylation of the alpha-subunits of Gi and Go by cholera toxin (CTX). Such CTX-induced ADP ribosylation of Gi and Go occurs during G-protein interaction with an activated receptor. By measurement of the number of receptors in the membrane preparation used, the relative effectiveness of the two receptors was assessed. The alpha2-adrenergic receptor was found to be markedly more effective than the galanin receptor in activating G-proteins.


Subject(s)
GTP-Binding Proteins/metabolism , Galanin/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Norepinephrine/pharmacology , Receptors, Adrenergic, alpha-2/physiology , Receptors, Gastrointestinal Hormone/physiology , Adenosine Diphosphate Ribose/metabolism , Animals , Cell Line , Cell Membrane/physiology , Cholera Toxin/metabolism , Clonidine/metabolism , GTP Phosphohydrolases/metabolism , Islets of Langerhans , Kinetics , NAD/metabolism , Receptors, Galanin
SELECTION OF CITATIONS
SEARCH DETAIL
...